Tocilizumab in systemic lupus erythematosus: Data on safety, preliminary efficacy, and impact on circulating plasma cells from an open-label phase I dosage-escalation study
Gabor G. Illei, Yuko Shirota, Cheryl H. Yarboro, Jimmy Daruwalla, Edward Tackey, Kazuki Takada, Thomas Fleisher, James E. Balow, Peter E. LipskyVolume:
62
Année:
2010
Langue:
english
Pages:
11
DOI:
10.1002/art.27221
Fichier:
PDF, 206 KB
english, 2010